Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Fulgent Diagnostics
AddedFeb 17, 2024
UpdatedJun 28, 2026
Fulgent Diagnostics

Fulgent Diagnostics

Public

California-based Fulgent Diagnostics offers specialized genetic, cancer, and COVID-19 testing services.

HQ
Temple City, CA, US
Founded
2011
Overview
Compare
Employees
Website

Founded in Temple City, California, Fulgent Diagnostics is dedicated to advancing healthcare through specialized genetic testing. The company's core mission is to provide comprehensive and accurate diagnostic solutions that empower patients and healthcare providers. Their services include genetic testing, cancer panel testing, and COVID-19 testing, catering to a diverse market that spans individuals seeking personalized medical insights to large healthcare institutions requiring reliable diagnostic tools.

Fulgent Diagnostics has garnered attention for its innovative approach and robust testing capabilities. Key figures associated with the company include industry experts and investors who have recognized the potential of advanced genetic diagnostics. The company has achieved significant milestones, such as expanding its testing portfolio and playing a crucial role in COVID-19 testing during the pandemic. Overall, Fulgent Diagnostics has made a substantial impact on the medical diagnostics field, contributing to more informed healthcare decisions and improved patient outcomes.

Fulgent Diagnostics - Similar Companies

Fulgent Genetics logo

Fulgent Genetics

Invitae logo

Invitae

invitae.com

Juno Diagnostics logo

Juno Diagnostics

Empowered Diagnostics logo

Empowered Diagnostics

Quest Diagnostics logo

Quest Diagnostics

GeneDx Holdings logo

GeneDx Holdings

genedx.com

Pathway Genomics logo

Pathway Genomics

Gentec logo

Gentec

Color logo

Color

color.com

Genetica logo

Genetica

genetica.asia

Predictive Health Diagnostics Company logo

Predictive Health Diagnostics Company

Fit Genetics logo

Fit Genetics

Iverson Genetic Diagnostics logo

Iverson Genetic Diagnostics

23andMe logo

23andMe

23andme.com

Test Diagnostics logo

Test Diagnostics

Fulgent Diagnostics - Quick Facts

Who are Fulgent Diagnostics' competitors?

Companies similar to Fulgent Diagnostics include Fulgent Genetics, Invitae, Juno Diagnostics and Empowered Diagnostics.

When was Fulgent Diagnostics founded?

Fulgent Diagnostics was founded in 2011.

Where is Fulgent Diagnostics' headquarters located?

Fulgent Diagnostics' headquarters is located in Temple City, CA, US.

How many employees does Fulgent Diagnostics have?

Fulgent Diagnostics has 375 employees as of Feb 10, 2024.

Fulgent Diagnostics - Classification

Ownership
  • Public
Technology
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Software
  • Transactional
Customer
  • Consumers
  • Enterprise
Main Product
  • COVID Testing
  • Genetic Testing
Tags
  • Biotech
  • Data
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified